DETERMINING THE POTENTIAL FOR SUCCESS
Our assessment defines the enhancements, values and outcomes we can generate for you.
With our unique capabilities in precision immune oncology we can help companies enhance their targeting capability and accelerate their scientific development. Javelin has a two-step process for customer engagement. Our first step is an assessment where in 4-10 weeks we evaluate your current efforts and identify the impact that we can provide. Our second step is deployment where we execute a customized solution tailored specifically to your needs to unleash significant productivity benefits and savings.
OUR ASSESSMENT DETERMINES
- Probabilistic success of your targets
- Extent that refined stratification can alter probabilities
- Extent of patient response rate and at what level
- Optimal trial size and potential availability and location of patients
Validate and Enhance Search Targets
Potential therapies require significant resources to determine their effectiveness. We have the ability to give you a probabilistic assessment to predict which targets hold the greatest likelihood for failure or success and how to enhance positive targets with improved stratification.
Vastly Reduce Cost and Time of Clinical Trials
For promising targets we can help you reduce the costs of future clinical trials by significantly reducing the requisite patient census for the trial. We enable this by pre-selecting patients most likely to respond a therapy and enhance the probability of success of these therapies under development.
Customize Your Deployment Plan
Based on our assessment you will have a clear scope on our deployment and what the ROI will be for your organization from utilizing Javelin services. In the rare case we can’t make material improvements you will have a strong validation of your approach.
Learn more about how Javelin Oncology can help you accelerate your immuno-oncology therapy development pipeline
Javelin assesses the level of saving and improvements that can be delivered